Dr. Ray Zuo receives the Investigator Award, which is given to junior investigators in the period between completing post-doctoral fellowship training while being competitive for more significant funding and establishing themselves as independent investigators. Read more.

Dr. Jason Knight is selected for the Edmund L. Dubois, MD Memorial Lectureship, which is given annually to an outstanding investigator in the area of lupus research. Read more.

Ray Zuo, MD joined Michigan Medicine on November 1, 2019 as a Clinical Assistant Professor in the Division of Rheumatology. Dr. Zuo's focus is on Antiphospholipid Syndrome (APS) and is working on the APS Program with Dr. Jason Knight. Read more.

Lupus Research Alliance Target Identification in Lupus Grants Awarded

Jason Knight, MD, PhD is awarded a Lupus Research Alliance grant to study whether a stress-sensing protein spurs neutrophils to release NETs in patients with lupus. Read more.

Dr. Jason Knight Named Marvin and Betty Danto Research Professor of Connective Tissue Research

Jason Knight, MD, PhD is named Marvin and Betty Danto Research Professor of Connective Tissue Research.

Q&A with New Research Fellow, Dr. Hui Shi

Hui Shi, MD, PhD is a new research fellow and the latest addition to Dr. Jason Knight’s lab. Prior to coming to Ann Arbor, Dr. Shi worked as a rheumatologist at Shanghai Ruijin Hospital, a well-known hospital in China. Read more.

Impeding White Blood Cells in Antiphospholipid Syndrome Reduced Blood Clots

A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition. Read more.

U-M Rheumatology Division, Faculty Spotlight, Dr. Jason Knight

Jason S. Knight, MD, PhD earned both his MD and PhD degrees from the University of Michigan, and completed the majority of his PhD thesis while at the University of Pennsylvania. Read more.

Lupus Research Alliance

Dr. Jason Knight receives grant to determine whether neutrophil elastase is a good target for the development of a new type of treatment for people with lupus. Read more.